Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM)

N/A

Report date: 2025/02/07 20:00:46

Base Information

Drug NameControlled-Ileocolonic-Release Nicotinamide (CICR-NAM)
Drug Alias NameCICR-NAM
ClassificationSmall molecules > Amino acid supplement, Lipids and Vitamins
Mechanisms of ActionMitogen-activated protein kinase inhibitors
TargetsMitogen-activated protein kinase
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Hospitals Of Schleswig-Holstein
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Hospitals Of Schleswig-Holstein
Inactive CompaniesN/A
Active IndicationsColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A